The 14th Anglonordic Life Science Conference will take place at the prestigious 8 Northumberland Avenue, just a few steps from Trafalgar Square in central London.
Decision makers from leading and upcoming drug discovery and medtech companies in the Anglo-Nordic regions will network with international pharma and investment firms. Last year, 85 investors representing 70 investment firms attended the event, which starts off with an exclusive reception.
The conference includes two main conference rooms; biotech and medtech. The Biotech investment programme includes topics like Building an IP portfolio to enhance value, a Nordic overview and Opportunities and challenges for new spin-outs. The technologies room programme includes a status update on the medtech industry, a keynote on digital health and Swedish government on industry strength through collaboration.